-+ 0.00%
-+ 0.00%
-+ 0.00%

SEISMIC PHARMACEUTICALS COMMENCES GLOBAL PHASE 3 TRIAL OF ISTAROXIME IN PATIENTS WITH CARDIOGENIC SHOCK

Reuters·09/09/2026 20:05:19

Please log in to view news